Literature DB >> 5385158

Factors affecting serum inhibited growth of Candida albicans and Cryptococcus neoformans.

A T Hendry, A Bakerspigel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5385158

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


× No keyword cloud information.
  8 in total

Review 1.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

Review 2.  The in vitro interactions of Candida albicans with nonspecific serum proteins.

Authors:  H F Hasenclever
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

3.  5-fluorocytosine and urinary candidiasis.

Authors:  R R Davies; D S Reeves
Journal:  Br Med J       Date:  1971-03-13

4.  Characterization of an anticryptococcal protein isolated from human serum.

Authors:  S Sridhar; M Ahluwalia; E Brummer; D A Stevens
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  In vitro interactions of immune lymphocytes and Cryptococcus neoformans.

Authors:  P Y Fung; J W Murphy
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.

Authors:  S L Newman; L Gootee; G Brunner; G S Deepe
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Further studies on the intracellular behavior of Torulopsis glabrata.

Authors:  V Otto; D H Howard
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

8.  Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans.

Authors:  Kevin Kim; Leeor Zilbermintz; Mikhail Martchenko
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-06-09       Impact factor: 3.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.